β-Catenin expression is altered in dysplastic and nondysplastic aberrant crypt foci of human colon

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 4, 2009, Pages 294-300

  Mi, Biantao ^a   Wang, Xinying ^a   Bai, Yang ^a   Gong, Wei ^a   Wang, Xuantong ^b   Geng, Yan ^a   Wang, Jing ^a   Zhang, Hongquan ^c   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

catenin protein; Aberrant crypt foci; Colon tumorigenesis; Nondysplasia

Indexed keywords

BETA CATENIN; INDIGO CARMINE;

ABERRANT CRYPT FOCI; ADULT; ARTICLE; CELLULAR DISTRIBUTION; CHROMOENDOSCOPY; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM BIOPSY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BIOPSY; COLON; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 68149159339     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318194525c     Document Type: Article

References (40)

1. Seike K, Koda K, Oda K, et al. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms. Am J Gastroenterol. 2006;101:1362-1369. (Pubitemid 43830006)
2. Stevens RG, Swede H, Rosenberg DW. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett. 2007;252:171-183. (Pubitemid 46809786)
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159-170.
4. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl JMed. 1998; 339:1277-1284. (Pubitemid 28496193)
5. Greenspan EJ, Cyr JL, Pleau DC, et al. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis. 2007;28:769-776.
6. Nucci MR, Robinson CR, Longo P, et al. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol. 1997;28:1396-1407. (Pubitemid 28013636)
7. Roncucci L, Pedroni M, Vaccina F, et al. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1-18. (Pubitemid 30162619)
8. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA. 1990;87: 4246-4250. (Pubitemid 20218018)
9. Sena P, Saviano M, Monni S, et al. Subcellular localization of β-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions. Cancer Lett. 2006;241:203-212. (Pubitemid 44163032)
10. Hao XP, Pretlow TG, Rao JS, et al. b-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res. 2001;61: 8085-8088. (Pubitemid 33091594)
11. Chung GG, Provost E, Kielhorn EP, et al. Tissue microarray analysis of β-catenin in colorectal cancer shows nuclear phosphob- catenin is associated with a better prognosis. Clin Cancer Res. 2001; 7:4013-4020. (Pubitemid 34044621)
12. Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3b. Science. 1998;280:596-599. (Pubitemid 28227764)
13. Mann B, Gelos M, Siedow A, et al. Target genes of β-catenin-T cellfactor/ lymphoid enhancer factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA. 1999;96:1603-1608. (Pubitemid 29098498)
14. Ilyas M, Straub J, Tomlinson I PM, et al. Genetic pathways in colorectal and other cancers. Eur J Cancer. 1999;35:335-351. (Pubitemid 29151929)
15. He TC, Sparks AB, Rago C, et al. Identification of c-myc as a target of the APC pathway. Science. 1998;281:1509-1512. (Pubitemid 28425575)
16. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422-426. (Pubitemid 29180374)
17. Brabletz T, Jung A, Dag S, et al. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999;155:1033-1038. (Pubitemid 29488909)
18. Cohen G, Mustafi R, Chumsangsri A, et al. Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci. Cancer Res. 2006;66:5656-5664. (Pubitemid 43927118)
19. Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett. 2000; 112-3:395-402. (Pubitemid 30138150)
20. Siu IM, Pretlow TG, Amini SB, et al. Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol. 1997;150: 1805-1813. (Pubitemid 27193826)
21. Roncucci L, Stamp D, Medline A, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991;22:287-294.
22. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev. 1991;1:57-60.
23. Roncucci L. Early events in human colorectal carcinogenesis: aberrant crypts and microadenoma. J Gastroenterol. 1992;24: 498-501.
24. Di Gregorio C, Losi L, Fante R, et al. Histology of aberrant crypt foci in the human colon. Histopathology. 1997;30:328-334. (Pubitemid 27168792)
25. Chiang JM, Chou YH, Chen TC, et al. Nuclear b-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br J Cancer. 2002;86:1124-1129.
26. Hao X, Tomlinson I, Ilyas M, et al. Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumours. Virchows Arch. 1997;431:167-172. (Pubitemid 27440360)
27. Hao XP, Pretlow TG, Rao JS, et al. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res. 2001;61: 419-422.
28. Preston SL, Wong WM, Chan AO, et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res. 2003;63:3819-3825.
29. Johnston MD, Edwards CM, Bodmer WF, et al. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc Natl Acad Sci U S A. 2007;104:4008-4013.
30. Iwamoto M, Ahnen DJ, Franklin WA, et al. Expression of b-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis. 2000;21:1935-1940. (Pubitemid 30843725)
31. Van den Brink GR, Offerhaus GJ. The morphogenetic code and colon cancer development. Cancer Cell. 2007;11:109-117.
32. Fodde R, Brabletz T. Wnt/β-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150-158. (Pubitemid 46386404)
33. Daniel W, Shi Yang, Devon C. Mutations in BRAF and KRAS differentially distinguish serrated versus non-Serrated hyperplastic aberrant crypt foci in humans. Cancer Res. 2007;67: 3551-3554.
34. Smith AJ, Stern HS, Penner M, et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res. 1994;54:5527-5530. (Pubitemid 24346239)
35. Pretlow TP, Pretlow TG. Human aberrant crypt foci: c-myc and β-catenin expressions are altered more often than APC expression. Cancer Res. 2002;43:519-520.
36. Pretlow TP, Pretlow TG. Mutant K-ras in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta. 2005;1756:83-96.
37. Nambiar PR, Boutin SR, Raja R, et al. Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia. Vet Pathol. 2005;42:735-752. (Pubitemid 41695358)
38. Emmert Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001.
39. Kuhn DE, Roy S, Radtke J, et al. Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes. Am J Physiol Heart Circ Physiol. 2007;292:H1245-H1253. (Pubitemid 46377109)
40. Mueller JD, Bethke B, Stolte M. Colorectal de novo carcinoma: a review of its diagnosis, histopathology, molecular biology, and clinical relevance. Virchows Arch. 2002;440:453-460. (Pubitemid 34591728)